Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Comment by C10H12N2on Apr 07, 2023 10:06am
99 Views
Post# 35384548

RE:RE:RE:RE:RE:HUGE NEWS : $4 MILLION IN FUNDING FROM NRC

RE:RE:RE:RE:RE:HUGE NEWS : $4 MILLION IN FUNDING FROM NRC
The premise of both of your replies are repetitively hostile as they always have been in the past. Whether you're the intended person of my posts or not you like Psychological Projection. Also known as Gaslighting. You want to blame others for exactly that which you are doing. You can't belittle my opinions because all my opinion are grounded in my truths. I'm not here to carry anyone's water like a corporate water boy. That appears to be your #1 job here and CEO.CA. Some things will never change. Just like the stagnation of the stock price for whatever reason(s) you conjure up next. I'm sorry to see your coveted Arch stock play hasn't reached your intended Promise Land as of yet. Maybe next try wishing for a 75% chance of success. That should do the trick!
<< Previous
Bullboard Posts
Next >>